1. Home
  2. REPL vs CTEV Comparison

REPL vs CTEV Comparison

Compare REPL & CTEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • CTEV
  • Stock Information
  • Founded
  • REPL 2015
  • CTEV 1980
  • Country
  • REPL United States
  • CTEV United States
  • Employees
  • REPL 479
  • CTEV N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • CTEV
  • Sector
  • REPL Health Care
  • CTEV
  • Exchange
  • REPL Nasdaq
  • CTEV NYSE
  • Market Cap
  • REPL 239.0M
  • CTEV 794.4M
  • IPO Year
  • REPL 2018
  • CTEV N/A
  • Fundamental
  • Price
  • REPL $3.15
  • CTEV $39.66
  • Analyst Decision
  • REPL Buy
  • CTEV Buy
  • Analyst Count
  • REPL 10
  • CTEV 1
  • Target Price
  • REPL $8.25
  • CTEV $44.00
  • AVG Volume (30 Days)
  • REPL 9.2M
  • CTEV 165.5K
  • Earning Date
  • REPL 08-07-2025
  • CTEV 08-06-2025
  • Dividend Yield
  • REPL N/A
  • CTEV N/A
  • EPS Growth
  • REPL N/A
  • CTEV N/A
  • EPS
  • REPL N/A
  • CTEV N/A
  • Revenue
  • REPL N/A
  • CTEV $927,446,000.00
  • Revenue This Year
  • REPL N/A
  • CTEV $2.40
  • Revenue Next Year
  • REPL N/A
  • CTEV $3.12
  • P/E Ratio
  • REPL N/A
  • CTEV N/A
  • Revenue Growth
  • REPL N/A
  • CTEV N/A
  • 52 Week Low
  • REPL $2.68
  • CTEV $4.80
  • 52 Week High
  • REPL $17.00
  • CTEV $51.29
  • Technical
  • Relative Strength Index (RSI)
  • REPL 24.82
  • CTEV N/A
  • Support Level
  • REPL $2.68
  • CTEV N/A
  • Resistance Level
  • REPL $3.85
  • CTEV N/A
  • Average True Range (ATR)
  • REPL 0.80
  • CTEV 0.00
  • MACD
  • REPL -1.03
  • CTEV 0.00
  • Stochastic Oscillator
  • REPL 4.45
  • CTEV 0.00

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About CTEV CLARITEV CORPORATION

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Share on Social Networks: